Profluent is an innovative AI-first protein design company founded in 2022, located in Emeryville, CA. The company focuses on developing deep generative models to design and validate novel, functional proteins aimed at transforming biomedicine. With over $150 million raised from prominent investors such as Altimeter Capital, Bezos Expeditions, and Spark Capital, Profluent is positioned at the forefront of the intersection between artificial intelligence and biology, driving advancements across various sectors including therapeutics, diagnostics, and agriculture.